Pamela Vergara-Rodriguez

Summary

Publications

  1. doi request reprint Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness
    Pamela Vergara-Rodriguez
    The Ruth M Rothstein CORE Center, Cook County Health and Hospital System, Chicago, IL 60612, USA
    Pharmacol Ther 124:269-78. 2009
  2. doi request reprint Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients
    Pamela Vergara-Rodriguez
    The CORE Center, Chicago, IL, USA
    J Acquir Immune Defic Syndr 56:S62-7. 2011

Detail Information

Publications2

  1. doi request reprint Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness
    Pamela Vergara-Rodriguez
    The Ruth M Rothstein CORE Center, Cook County Health and Hospital System, Chicago, IL 60612, USA
    Pharmacol Ther 124:269-78. 2009
    ..Finally, recommendations for monitoring and managing the intersecting, growing population of HIV/AIDS patients with severe mental illness are provided...
  2. doi request reprint Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients
    Pamela Vergara-Rodriguez
    The CORE Center, Chicago, IL, USA
    J Acquir Immune Defic Syndr 56:S62-7. 2011
    ..The safety of buprenorphine/naloxone (bup/nx) in HIV-infected patients has not been established. Prior reports raise concern about hepatotoxicity and interactions with atazanavir...